Updated Date: Fri, 26 May 2023 00:00:00 EDT

The results of a new clinical trial suggest that the first drug therapy to slow the progression of […]

Modern medicine has been shaped by technology, but there’s no guarantee that the newest iteration of a medical […]

The final draft guidance recommends rimegepant for adults who have at least four migraine attacks per month, but […]

BI-1910 is now the second of the company’s anti-tumour necrosis factor receptor 2 programmes to enter clinical development

Updated Date: Thu, 25 May 2023 00:00:00 EDT

The online version of this obituary (doi:10.1136/bmj.p695, published 23 March 2023) features a photograph of Traute Lafrenz, as […]

Synaffix’s technology platform is intended to enhance and extend Lonza’s integrated ADC services

Nitisinone capsules are indicated for patients with hereditary tyrosinemia type 1 in combination with dietary restriction of tyrosine […]

Scanning for pulmonary embolismWe all know that feeling when a colleague comes up to you with a grave […]